Acceleron Pharma reported earnings of ($0.63) per share beat views
Acceleron Pharma (NASDAQ:XLRN) reported Q2 2018 earnings, coming in at ($0.63) per share, beating Wall Street’s estimates of ($0.65) per Share. Revenue for the quarter came in at $3.69 million beating analyst estimates of $3.37 million
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.